| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Mai―14 |
Lyophilized MSC-EVs attenuates COVID-19 pathogenesis by regulating the JAK/STAT pathway |
Nesrine Ebrahim, Hajir A. Al Saihati, Zahraa Alali, Sabry Younis Mohamed Mahmoud, Ali A. Rabaan, Arigue A. Dessouky, Rabab F. Salim, Ashraf A. Shamaa, Ahmed N. Abdallah, Nehal M. Elsherbiny, Gamal Othman, Abdelnaser A. Badawy, Gianpiero Di Leva, Omnia A. Badr |
| 2 |
[GO] |
2025―Feb―25 |
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial |
Meng-Qi Yuan, Le Song, Ze-Rui Wang, Zi-Ying Zhang, Ming Shi, Junli He, Qiong Mo, Ning Zheng, Wei-Qi Yao, Yu Zhang, Tengyun Dong, Yuanyuan Li, Chao Zhang, Jinwen Song, Lei Huang, Zhe Xu, Xin Yuan, Jun-Liang Fu, Cheng Zhen, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei-Fen Xie, Yonggang Li, Bo Zhang, Lei Shi, Fu-Sheng Wang |
| 3 |
[GO] |
2025―Jan―23 |
Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection |
Kátia Nunes da Silva, Fernanda Martins Marim, Gisele Vieira Rocha, Zaquer Suzana Munhoz Costa-Ferro, Luciana Souza de Aragão França, Carolina Kymie Vasques Nonaka, Bruno Diaz Paredes, Erik Aranha Rossi, Erick Correia Loiola, Corynne Stephanie Ahouefa Adanho, Rachel Santana Cunha, Mayck Medeiros Amaral da Silva, Fernanda Ferreira Cruz, Vivian Vasconcelos Costa, Dalila Lucíola Zanette, Clarissa Araújo Gurgel Rocha, Renato Santana Aguiar, Patricia Rieken Macedo Rocco, Bruno Solano de Freitas Souza |
| 4 |
[GO] |
2024―Okt―16 |
Correction: MSC-extracellular vesicle microRNAs target host cell-entry receptors in COVID-19: in silico modeling for in vivo validation |
Hajer A. Al Saihati, Arigue A. Dessouky, Rabab F. Salim, Islam Elgohary, Mohamed El-Sherbiny, Fares E. M. Ali, Mahmoud M. A. Moustafa, Dalia Shaheen, Nicholas Robert Forsyth, Omnia A. Badr, Nesrine Ebrahim |
| 5 |
[GO] |
2024―Sep―20 |
MSC-extracellular vesicle microRNAs target host cell-entry receptors in COVID-19: in silico modeling for in vivo validation |
Hajer A. Al Saihati, Arigue A. Dessouky, Rabab F. Salim, Islam Elgohary, Mohamed El-Sherbiny, Fares E. M. Ali, Mahmoud M. A. Moustafa, Dalia Shaheen, Nicholas Robert Forsyth, Omnia A. Badr, Nesrine Ebrahim |
| 6 |
[GO] |
2024―Aug―13 |
Characteristics of HPC(A) product obtained from a donor with SARS-CoV-2 infection and outcome of autologous transplant |
Pranav S. Renavikar, Phyllis I. Warkentin, Shelly M. Williams, Krishna Gundabolu, Charles Branson, Scott A. Koepsell |
| 7 |
[GO] |
2024―Apr―19 |
Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life |
Alexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, Nicholas Heming, Julien Mayaux, Jean-Luc Diehl, Alexandre Demoule, Djillali Annane, Clémence Marois, Sophie Demeret, Emmanuel Weiss, Guillaume Voiriot, Muriel Fartoukh, Jean-Michel Constantin, Bruno Mégarbane, Gaëtan Plantefève, Hélène Boucher-Pillet, Guillaume Churlaud, Audrey Cras, Camille Maheux, Chloé Pezzana, Mamadou Hassimiou Diallo, Said Lebbah, Jacques Ropers, Joe-Elie Salem, Christian Straus, Philippe Menasché, Jérôme Larghero, Antoine Monsel, Déborah Benchetrit, Harold Bonvallot, Fanny Charbonnier-Beaupel, Meriem Dhib-Charfi, Pierre Romain Delmotte, Assitan Kone, Marine Le Corre, Carole Metz, Louis Puybasset, Corinne Vezinet |
| 8 |
[GO] |
2023―Dez―12 |
SARS-CoV-2-infected hiPSC-derived cardiomyocytes reveal dynamic changes in the COVID-19 hearts |
Xiao Li, Hengrui Hu, Wanlin Liu, Qiyu Zhang, Yujie Wang, Xingjuan Chen, Yunping Zhu, Zhihong Hu, Manli Wang, Jie Ma, Ling Leng |
| 9 |
[GO] |
2023―Dez―10 |
Plasma proteomics-based biomarkers for predicting response to mesenchymal stem cell therapy in severe COVID-19 |
Tian-Tian Li, Wei-Qi Yao, Hai-Bo Dong, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Lei Shi, Fu-Sheng Wang |
| 10 |
[GO] |
2023―Nov―06 |
Cell-based passive immunization for protection against SARS-CoV-2 infection |
Evan Sawula, Shane Miersch, Eric D. Jong, Chengjin Li, Fang-Yu Chou, Jean Kit Tang, Reza Saberianfar, Jeffrey Harding, Sachdev S. Sidhu, Andras Nagy |
| 11 |
[GO] |
2023―Sep―13 |
SARS-CoV-2 viral genes Nsp6, Nsp8, and M compromise cellular ATP levels to impair survival and function of human pluripotent stem cell-derived cardiomyocytes |
Juli Liu, Shiyong Wu, Yucheng Zhang, Cheng Wang, Sheng Liu, Jun Wan, Lei Yang |
| 12 |
[GO] |
2023―Jun―26 |
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial |
Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, Faezeh Shekari, Seyedeh-Esmat Hosseini, Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Hamidreza Jamaati, Naghmeh Khavandgar, Hediyeh Alemi, Hoda Madani, Abdoreza Nazari, Azadeh Amini, Seyedeh Nafiseh Hassani, Fatemeh Abbasi, Neda Jarooghi, Nasrin Fallah, Leila Taghiyar, Meysam Ganjibakhsh, Ensiyeh Hajizadeh-Saffar, Massoud Vosough, Hossein Baharvand |
| 13 |
[GO] |
2023―Mai―04 |
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials |
Qinxue Liu, Fengjie Ma, Yizhi Zhong, Gaojian Wang, Li Hu, Yaping Zhang, Junran Xie |
| 14 |
[GO] |
2023―Apr―28 |
The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy |
Toka A. Ahmed, Bassant Eldaly, Shadwa Eldosuky, Hoda Elkhenany, Azza M. El-Derby, Muhamed F. Elshazly, Nagwa El-Badri |
| 15 |
[GO] |
2023―Apr―18 |
The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study |
Dat Ngo, Jason Chen, Jose Tinajero, Ahmed Aribi, Shukaib Arslan, Guido Marcucci, Ryotaro Nakamura, Monzr M. Al Malki, Stephen J. Forman, Sanjeet Dadwal, Haris Ali |
| 16 |
[GO] |
2022―Aug―12 |
Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment |
Yuling Huang, Xin Li, Lina Yang |
| 17 |
[GO] |
2022―Jul―28 |
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment |
Hamid Reza Aghayan, Fatemeh Salimian, Atefeh Abedini, Samrand Fattah Ghazi, Masud Yunesian, Sepideh Alavi-Moghadam, Jalil Makarem, Keivan Majidzadeh-A, Ali Hatamkhani, Maryam Moghri, Abbas Danesh, Mohammad Reza Haddad-Marandi, Hassan Sanati, Fereshteh Abbasvandi, Babak Arjmand, Pourya Azimi, Ardeshir Ghavamzadeh, Ramin Sarrami-Forooshani |
| 18 |
[GO] |
2022―Jul―16 |
One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment |
Lei Shi, You Zheng, Zhi Cheng, Ningfei Ji, Changming Niu, Yan Wang, Tingrong Huang, Ruyou Li, Mao Huang, Xiaolin Chen, Lei Shu, Mingjing Wu, Kaili Deng, Jing Wei, Xueli Wang, Yang Cao, Jiaxin Yan, Ganzhu Feng |
| 19 |
[GO] |
2022―Jun―28 |
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial |
Najmeh Kaffash Farkhad, Alireza Sedaghat, Hamidreza Reihani, Amir Adhami Moghadam, Ahmad Bagheri Moghadam, Nayereh Khadem Ghaebi, Mohammad Ali Khodadoust, Rashin Ganjali, Amir Reza Tafreshian, Jalil Tavakol-Afshari |
| 20 |
[GO] |
2022―Jun―17 |
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19 |
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, Omid Gholizadeh, Hamed Rahmani Youshanlouei, Saeed Karimi Matloub, Masoud Mozafari, Elham Jokar, Yalda Yazdani, Mehdi Dadashpour |
| 21 |
[GO] |
2022―Mai―26 |
Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study |
Ying-Gang Zhu, Meng-meng Shi, Antoine Monsel, Cheng-xiang Dai, Xuan Dong, Hong Shen, Su-ke Li, Jing Chang, Cui-li Xu, Ping Li, Jing Wang, Mei-ping Shen, Cheng-jie Ren, De-chang Chen, Jie-Ming Qu |
| 22 |
[GO] |
2022―Apr―01 |
Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial |
Muhammad Karyana, Irawaty Djaharuddin, Lutfah Rif’ati, Mansyur Arif, Mi Kyung Choi, Nova Angginy, Aeri Yoon, Jumi Han, Fonny Josh, Dona Arlinda, Asvin Narulita, Faisal Muchtar, Rizki Auliah Bakri, s Irmansyah |
| 23 |
[GO] |
2022―Mrz―25 |
Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation |
Amirhesam Babajani, Kasra Moeinabadi-Bidgoli, Farnaz Niknejad, Hamidreza Rismanchi, Sepehr Shafiee, Siavash Shariatzadeh, Elham Jamshidi, Mohammad Hadi Farjoo, Hassan Niknejad |
| 24 |
[GO] |
2022―Mrz―24 |
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives |
Weiqi Yao, Lei Shi, Yun Zhang, Haibo Dong, Yu Zhang |
| 25 |
[GO] |
2022―Mrz―21 |
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial |
Carmen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Claudio Luciano Franck, Debora Regina Daga, Patrícia Shigunov, Marco Augusto Stimamiglio, Daniela Boscaro Marsaro, Bruna Schaidt, Andressa Micosky, Ana Paula de Azambuja, Cleverson Alex Leitão, Ricardo Rasmussen Petterle, Valderez Ravaglio Jamur, Isadora May Vaz, Antônio Paulo Mallmann, Hipólito Carraro Junior, Eduardo Ditzel, Paulo Roberto Slud Brofman, Alejandro Correa |
| 26 |
[GO] |
2022―Mrz―21 |
Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention |
Yan-Ruide Li, Zachary Spencer Dunn, Gustavo Garcia, Camille Carmona, Yang Zhou, Derek Lee, Jiaji Yu, Jie Huang, Jocelyn T. Kim, Vaithilingaraja Arumugaswami, Pin Wang, Lili Yang |
| 27 |
[GO] |
2022―Mrz―07 |
Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II |
Mina Fathi-Kazerooni, Samrand Fattah-Ghazi, Maryam Darzi, Jalil Makarem, Reza Nasiri, Faeze Salahshour, Seyed Ali Dehghan-Manshadi, Somaieh Kazemnejad |
| 28 |
[GO] |
2022―Feb―07 |
Clinical efficacy and mechanism of mesenchymal stromal cells in treatment of COVID-19 |
Kun Lu, Shi-tao Geng, Shikai Tang, Hua Yang, Wei Xiong, Fang Xu, Qijun Yuan, Xian Xiao, Renqiang Huang, Haihui Liang, Zhipeng Chen, Chuanyun Qian, Yang Li, Songqing Wang |
| 29 |
[GO] |
2022―Jan―15 |
Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury |
Ramana Vaka, Saad Khan, Bin Ye, Yousef Risha, Sandrine Parent, David Courtman, Duncan J. Stewart, Darryl R. Davis |
| 30 |
[GO] |
2022―Jan―10 |
When stem cells meet COVID-19: recent advances, challenges and future perspectives |
Shasha Li, Hecheng Zhu, Ming Zhao, Weidong Liu, Lei Wang, Bin Zhu, Wen Xie, Cong Zhao, Yao Zhou, Caiping Ren, Hui Liu, Xingjun Jiang |
| 31 |
[GO] |
2021―Aug―21 |
Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects |
Mai Abdelgawad, Nourhan Saied Bakry, Ahmed A. Farghali, Ahmed Abdel-Latif, Ahmed Lotfy |
| 32 |
[GO] |
2021―Jul―27 |
Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19? |
Kátia Nunes da Silva, André Luiz Nunes Gobatto, Zaquer Suzana Munhoz Costa-Ferro, Bruno Raphael Ribeiro Cavalcante, Alex Cleber Improta Caria, Luciana Souza de Aragão França, Carolina Kymie Vasques Nonaka, Fernanda de Macêdo Lima, Miquéias Lopes-Pacheco, Patricia Rieken Macêdo Rocco, Bruno Solano de Freitas Souza |
| 33 |
[GO] |
2021―Jul―16 |
Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial |
Mahshid Saleh, Amir Abbas Vaezi, Rasoul Aliannejad, Amir Ali Sohrabpour, Seyedeh Zahra Fotook Kiaei, Mahdi Shadnoush, Vahid Siavashi, Leila Aghaghazvini, Batoul Khoundabi, Shahriyar Abdoli, Bahram Chahardouli, Iman Seyhoun, Neda Alijani, Javad Verdi |
| 34 |
[GO] |
2021―Jul―15 |
Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction |
Anahid Safari, Vicenzo Lionetti, Iman Razeghian-Jahromi |
| 35 |
[GO] |
2021―Jun―02 |
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia |
Rachele Ciccocioppo, Davide Gibellini, Giuseppe Astori, Martina Bernardi, Angela Bozza, Katia Chieregato, Francesca Elice, Stefano Ugel, Simone Caligola, Francesco De Sanctis, Stefania Canè, Alessandra Fiore, Rosalinda Trovato, Antonio Vella, Varvara Petrova, Giuseppe Amodeo, Monica Santimaria, Annarita Mazzariol, Luca Frulloni, Marco Ruggeri, Enrico Polati, Vincenzo Bronte |
| 36 |
[GO] |
2021―Mai―12 |
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era |
Birbal Singh, Gorakh Mal, Vinod Verma, Ruchi Tiwari, Muhammad Imran Khan, Ranjan K. Mohapatra, Saikat Mitra, Salem A. Alyami, Talha Bin Emran, Kuldeep Dhama, Mohammad Ali Moni |
| 37 |
[GO] |
2021―Mrz―01 |
Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus? |
Rodrigo N. Riedel, Antonio Pérez-Pérez, Víctor Sánchez-Margalet, Cecilia L. Varone, Julieta L. Maymó |
| 38 |
[GO] |
2021―Jan―29 |
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series |
Seyed-Mohammad Reza Hashemian, Rasoul Aliannejad, Morteza Zarrabi, Masoud Soleimani, Massoud Vosough, Seyedeh-Esmat Hosseini, Hamed Hossieni, Saeid Heidari Keshel, Zeinab Naderpour, Ensiyeh Hajizadeh-Saffar, Elham Shajareh, Hamidreza Jamaati, Mina Soufi-Zomorrod, Naghmeh Khavandgar, Hediyeh Alemi, Aliasghar Karimi, Neda Pak, Negin Hossieni Rouzbahani, Masoumeh Nouri, Majid Sorouri, Ladan Kashani, Hoda Madani, Nasser Aghdami, Mohammad Vasei, Hossein Baharvand |
| 39 |
[GO] |
2021―Jan―04 |
Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19 |
Loubna Mazini, Mohamed Ezzoubi, Gabriel Malka |
| 40 |
[GO] |
2020―Nov―30 |
Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells |
Youjeong Kwon, Sarath Babu Nukala, Shubhi Srivastava, Hiroe Miyamoto, Nur Izzah Ismail, Jordan Jousma, Jalees Rehman, Sang-Bing Ong, Won Hee Lee, Sang-Ging Ong |
| 41 |
[GO] |
2020―Okt―15 |
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients |
Sara Al-Khawaga, Essam M. Abdelalim |
| 42 |
[GO] |
2020―Sep―18 |
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm |
Maria Kavianpour, Mahshid Saleh, Javad Verdi |
| 43 |
[GO] |
2020―Aug―18 |
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells |
Lei Shu, Changming Niu, Ruyou Li, Tingrong Huang, Yan Wang, Mao Huang, Ningfei Ji, You Zheng, Xiaolin Chen, Lei Shi, Mingjing Wu, Kaili Deng, Jing Wei, Xueli Wang, Yang Cao, Jiaxin Yan, Ganzhu Feng |
| 44 |
[GO] |
2020―Aug―14 |
Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia |
Ali Akbari, Jafar Rezaie |
| 45 |
[GO] |
2020―Jul―22 |
Mesenchymal stem cells: current clinical progress in ARDS and COVID-19 |
Kun Xiao, Fei Hou, Xiuyu Huang, Binbin Li, Zhi Rong Qian, Lixin Xie |
| 46 |
[GO] |
2020―Jul―16 |
A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report |
Hongbing Peng, Tiefeng Gong, Xiaoying Huang, Xun Sun, Hong Luo, Weizhong Wang, Junbiao Luo, Baowei Luo, Yanhui Chen, Xingxing Wang, Haifeng Long, Hua Mei, Chuang Li, Yanni Dai, Honghui Li |
| 47 |
[GO] |
2020―Mai―27 |
Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia |
Yingxin Zhang, Jie Ding, Shaoda Ren, Weihua Wang, Yapei Yang, Shuangjing Li, Min Meng, Tiejun Wu, Daliang Liu, Suochen Tian, Hui Tian, Shuangfeng Chen, Changhui Zhou |
| 48 |
[GO] |
2020―Mai―24 |
Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury |
Jiang Du, Han Li, Jie Lian, Xinxing Zhu, Liang Qiao, Juntang Lin |
| 49 |
[GO] |
2020―Mai―04 |
Mesenchymal stem cells as a potential therapy for COVID-19 |
Shan Liu, Danyi Peng, Huijun Qiu, Ke Yang, Zhou Fu, Lin Zou |
|
